A randomized, comparative open-label study on the efficacy of latanoprost and timolol in steroid induced ocular hypertension after photorefractive keratectomy

European Journal of Ophthalmology

Volumn 10, Issue 3, 2000, Pages 205-211

  Vetrugno, M ^a   Maino, A ^a   Quaranta, G M ^a   Cardia, L ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Latanoprost; PRK; Steroid induced ocular hypertension; Timolol; Uveo scleral outflow

Indexed keywords

DEXAMETHASONE; LATANOPROST; STEROID; TIMOLOL;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE TOXICITY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KERATECTOMY; MALE; MYOPIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033798815     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210001000303     Document Type: Article

References (53)

1. Effect of corticosteroids on intraocular pressure and fluid dynamics. I: The effect of dexamethasone in the normal eye
2. Effect of corticosteroids on intraocular pressure and fluid dynamics. II: The effect of dexamethasone in the glaucomatous eye
3. Topical corticosteroids and heredity in primary open-angle glaucoma
4. Study of topical corticosteroid response in glaucoma suspects and family members of established glaucoma patients
5. Intraocular pressure response to topical corticosteroids
6. Topical corticosteroid testing in glaucoma siblings
7. Tonographic survey of the close relatives of patients with chronic simple glaucoma
8. Diabetes mellitus and primary open-angle glaucoma
9. High myopia and primary open-angle glaucoma
10. Steroid-induced ocular hypertension in high myopia
11. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I: The demonstration of three levels of response
12. Steroid-induced glaucoma. A: Persistent evaluation of intraocular pressure. B: Histopathological aspects
13. Permanent glaucomatous visual loss after photorefractive keratectomy
14. Effect of fluorometholone (FLM) on the intraocular pressure of corticosteroid responders
15. The use of the 193 nm excimer laser for myopic photorefractive keratectomy in sighted eyes: A multicenter study
16. Comparative antinflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential
17. Two-year experience with excimer laser photorefractive keratectomy for myopia
18. Effect of corticosteroids in postoperative care following photorefractive keratectomies
19. Do topical corticosteroids have a role after following excimer laser photorefractive keratectomy?
20. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells
21. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial
22. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery
23. Myopic photorefractive keratectomy with the excimer laser. One year follow-up
24. Repeated excimer laser treatment after photorefractive keratectomy
25. Excimer laser photorefractive keratectomy in myopia. Second report from the Italian Multicenter Study Group
26. Pharmacotherapy of photorefractive keratectomy
27. Mean visual acuity
28. The effects of corneal thickness on applanation tonometry
29. Topical fluorometholone reduces stromal inflammation after photorefractive keratectomy
30. Corticosteroid glaucoma
31. Ultra-structural and morphometric study of corticosteroid glaucoma in rabbits
32. The drainage of acqueous humor
33. Prostaglandin production by human trabecular cells: In vitro inhibition by dexamethasone
34. Eicosanoid production and glucocorticoid regulatory mechanisms in cultured human trabecular meshwork cells
35. Effects of PhXA41, a new prostaglandine analog, on aqueous humour dynamics in human eyes
36. Ocular penetration and bioconversion of prostaglandin F2a prodrugs in rabbit comea and conjunctiva
37. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro
38. Prostaglandin action on ciliary smooth muscle extra-cellular matrix metabolism: Implications for uveoscleral outflow
39. Sites of disruption of the blood-aqueous barrier after application of prostaglandin E2 in pigmented rabbits
40. Functional characterization of the ocular prostaglandin F2a (PGF2a) receptor. Activation by the isoprostane, 12-iso-PGF2a
41. Glaucoma: A physiologic perspective with Darwinian overtones
42. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit
43. Latanoprost and herpes simplex keratitis
44. Anterior uveitis associated with latanoprost
45. Cystoid macular edema and anterior uveitis associated with latanoprost use
46. Adverse side effects associated with latanoprost
47. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension
48. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning
49. A six-month, randomized, double masked study comparing latanoprost with timolol in open angle glaucoma and ocular hypertension
50. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States
51. Topical non steroidal agents and corneal wound healing
52. Effect of diclofenac on corneal haze after photorefractive keratectomy in rabbits